Alentemol
 | |
| Names | |
|---|---|
| IUPAC name
2-(Dipropylamino)-2,3-dihydro-1H-phenalen-5-ol | |
| Identifiers | |
| 112891-97-1 | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL2104081 |
| ChemSpider | 54603 |
| PubChem | 60574 |
| |
| |
| Properties | |
| C19H25NO | |
| Molar mass | 283.42 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.[1][2]
References
- ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 143–. ISBN 978-0-8155-1856-3.
- ↑ A.F. Casy (11 November 2013). The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. Springer Science & Business Media. pp. 178–. ISBN 978-1-4899-2397-4.
This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.